By Scientia Professor Gregory John Dore

Journal articles

Stiboy E; Valerio H; Tillakeratne S; Sheppeard V; Parry AE; Katelaris AL; Dore GJ, 2026, 'Corrigendum to: Factors associated with delayed diagnosis of hepatitis B in southeastern Sydney', Public Health Research Practice, 36, http://dx.doi.org/10.1071/PU25052_CO

Conway A; Grebely J; Tillakeratne S; Cunningham EB; Munyengeterwa U; Van Dyk J; Martinello M; Carson J; Lafferty L; Bull RA; Horsburgh B; McGrath C; Brown T; Treloar C; Amin J; Degenhardt L; Applegate TL; Dunlop A; Matthews GV; Dore GJ; Lloyd AR; Hajarizadeh B, 2026, 'Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study', International Journal of Drug Policy, 151, http://dx.doi.org/10.1016/j.drugpo.2026.105234

Qian J; Stepien S; Cheng A; Shaw JE; Macartney K; Rowe SL; Thompson K; Dore GJ; Kaldor J; Newall AT; Wood J; Sparke C; O’Donnell B; Lambert SB; Matthews GV; Abbenbroek B; Liu B, 2026, 'New-onset diabetes following SARS-CoV-2 infection in the Omicron era: a matched cohort study', International Journal of Epidemiology, 55, http://dx.doi.org/10.1093/ije/dyag009

Stiboy E; Valerio H; Tillakeratne S; Sheppeard V; Parry AE; Katelaris AL; Dore GJ, 2026, 'Factors associated with delayed diagnosis of hepatitis B in southeastern Sydney', Public Health Research Practice, 36, http://dx.doi.org/10.1071/PU25052

Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Roth M; Willing AR; Sazzad HMS; Marshall AD; Fontaine G; Conway A; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Lafferty L; Lloyd A; Sheehan Y; Akiyama MJ; Kronfli N; Cabezas J; Grebely J, 2026, 'Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison: a systematic review and meta-analysis', International Journal of Drug Policy, 149, http://dx.doi.org/10.1016/j.drugpo.2025.105082

Stowe MJ; Conway A; Altice FL; College-Frisby S; Read P; Montebello M; Whitton G; Hayllar J; Daglish M; Cock V; Christmass M; Crawford S; Henderson C; Dore GJ; Gough C; Farrell M; Degenhardt L; Grebely J, 2026, 'Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70079

McKetin R; Shoptaw S; Saunders L; Nguyen L; Clare PJ; Dore GJ; Turner A; Dean OM; Kelly PJ; Arunogiri S; Koeijers J; Degan TJ; Degenhardt L; Farrell M; Goodman-Meza D; Sinclair B; Reid D; Cordaro F; Hill H; Lundin R; Hayllar J; Christmass M; Liaw W; Liu D; Woods A; Brewerton B; Holyoak E; Wu BTF; Maher H; O’Dea N; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Kiden G; Romeo V; Kyaw KWY; Byrne M; Colledge-Frisby S; Zahra E; Berk M, 2026, 'Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial', JAMA Psychiatry, http://dx.doi.org/10.1001/jamapsychiatry.2026.0159

Hosseini-Hooshyar S; Valerio H; Flynn E; Sexton C; Barzi F; Amarasena S; De Koster L; Sellen D; Winterfield N; Grebely J; Matthews GV; Boyd MA; Applegate TL; Petoumenos K; Lafferty L; Dore GJ; Treloar C; Martinello M; Ward J, 2025, 'A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C study', BMC Infectious Diseases, 25, http://dx.doi.org/10.1186/s12879-025-12004-z

MacLachlan JH; Romero N; Lambert SB; Dore GJ; Gray RT; Kwon JA; Cowie BC, 2025, 'Jurisdictional movement among people with hepatitis B and C in Australia: implications for national data', Public Health Research and Practice, 36, http://dx.doi.org/10.1071/PU25051

Montague C; Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2025, 'Prevalence and engagement with healthcare services for hepatitis B infection among people in prison in Australia: the AusHep study', International Journal of Drug Policy, 146, http://dx.doi.org/10.1016/j.drugpo.2025.105035

Carson JM; Dore GJ, 2025, 'Learning From the Gaps: Rethinking Hepatitis C Virus Retreatment for People Who Inject Drugs', Clinical Infectious Diseases, 81, pp. 931 - 933, http://dx.doi.org/10.1093/cid/ciaf083

Bah R; Sheehan Y; Li X; Price N; Butler T; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B, 2025, 'Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons', International Journal of Drug Policy, 144, http://dx.doi.org/10.1016/j.drugpo.2024.104401

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Corrigendum to “Missed opportunities in HCV care: Trends in late diagnosis and treatment” (JHEP Reports (2025) 7(9), (S2589555925001521), (10.1016/j.jhepr.2025.101474))', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101561

Maher L; Wand H; Heard S; Starr M; Zolala F; Kemp R; Cunningham P; Drummer H; Hellard M; Kaldor J; Dore G, 2025, 'Utilising integrated bio-behavioural surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey', International Journal on Drug Policy, 144, pp. 104576, http://dx.doi.org/10.1016/j.drugpo.2024.104576

Masters J; Goodman-Meza D; Russell D; Marks L; McCreary E; Jacka B; Seear K; Davis JS; Matthews G; Martinello M; Tong SYC; Dore GJ, 2025, 'Bacterial and fungal infections in persons who inject drugs', Clinical Microbiology Reviews, 38, http://dx.doi.org/10.1128/cmr.00162-23

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Missed opportunities in HCV care: Trends in late diagnosis and treatment', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101474

Stevens A; Abbott J; Gribbin L; Ahmed S; Montebello M; Ellis-Jones P; Lam T; Jefferies M; O'Flynn M; O'Loan J; Wade A; Hoskins A; Johnson L; Johns A; Cock V; Harrod ME; Silk D; Marshall AD; Dore GJ; Grebely J; Cunningham EB, 2025, 'Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT study', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104871

Ang J; Hajarizadeh B; Tillakeratne S; Dore GJ; Treloar C; Amin J; van Dyk J; Degenhardt L; Applegate T; Dunlop A; Fraser C; Conway B; Wong A; Fuchs D; Powis J; Mason K; Gane EJ; Weltman M; Read P; Martinello M; Rowe E; Baker DA; Wade A; Matthews G; Lafferty L; Lloyd A; Grebely J; Cunningham EB, 2025, 'Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104859

Ivancovsky Wajcman D; Nicolàs A; Picchio CA; van Selm L; Dusheiko G; Younossi ZM; Dillon JF; Alqahtani SA; Razavi H; Colombo MG; Kautz A; Dore GJ; Lazarus JV, 2025, 'Prioritising viral hepatitis elimination to prevent hepatocellular carcinoma: A public health approach for effective preventive hepatology', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101436

Legrand NM; Bull RA; Hajarizadeh B; Lloyd AR; Johnston K; Issa K; Harvey C; Arnott A; Dwyer DE; Sintchenko V; Grant L; Dore GJ; Kaldor J; Martinello M, 2025, 'Surveillance of Viral Respiratory Infections within Maximum-Security Prison, Australia', Emerging Infectious Diseases, 31, pp. 1527 - 1536, http://dx.doi.org/10.3201/eid3108.240571

Hiebert-Suwondo L; Manning J; Tohme RA; Buti M; Kondili LA; Spearman CW; Prabdial-Sing N; Turnier V; Lazarus JV; Waked I; Ward JW; Miranda A; Sugiyama A; Hajarizadeh B; Varaldo C; Thomas C; Muñoz C; Leeman D; Dore G; Desalegn H; Aberra H; Cheinquer H; Qureshi H; Ivanchuk I; Grebely J; García-Samaniego J; Tanaka J; Tint KS; Poovorawan K; De Feo ME; Sonderup M; Aleksandrova M; Ali M; Hassany M; Marinho R; Hamid S; Punpetch S; Naing TS; Tanaka-Kumadai Y; Lim YS; Nartey Y, 2025, 'A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles', Lancet Gastroenterology and Hepatology, 10, pp. 671 - 684, http://dx.doi.org/10.1016/S2468-1253(25)00069-X

Byrne CD; Dore GJ, 2025, 'Metabolic dysfunction-associated steatotic liver disease a multisystem disease: Assessing the cost effectiveness of pharmacotherapies', Journal of Hepatology, 83, pp. 8 - 10, http://dx.doi.org/10.1016/j.jhep.2025.02.001

Goodman-Meza D; Weiss RE; Poimboeuf ML; Feng J; Vijayan T; Martinello M; Matthews GV; Dore GJ, 2025, 'Comparative Effectiveness of Long-Acting Lipoglycopeptides vs Standard-of-Care Antibiotics in Serious Bacterial Infections', JAMA Network Open, 8, http://dx.doi.org/10.1001/jamanetworkopen.2025.11641

Sazzad HMS; Li H; Hajarizadeh B; Horsburgh BA; Grebely J; Dore GJ; Bull RA; Lloyd AR; Rodrigo C, 2025, 'Estimating the impact of direct acting antiviral therapy on the prevalence of hepatitis C virus infection using phylogenetics', Virus Research, 355, http://dx.doi.org/10.1016/j.virusres.2025.199566

Masters J; Jacka B; Barault M; Goodman-Meza D; Russell D; Matthews GV; Dore GJ; Valerio H; Martinello M, 2025, 'Incidence, Patient-Directed Discharge, Readmission, and Mortality Among People Hospitalized With Injecting-Related Infection: A Population-Based Linkage Study', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf257

Jacka BP; Cheng QL; Schiavone B; Darley DR; Kelleher AD; Dore GJ; Matthews GV, 2025, 'Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf142

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; George J; Matthews G; Grebely J; Pearson SA; Dore GJ, 2025, 'Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia', International Journal of Drug Policy, 139, http://dx.doi.org/10.1016/j.drugpo.2025.104790

Artenie A; Trickey A; Looker KJ; Stone J; Lim AG; Fraser H; Degenhardt L; Dore GJ; Grebely J; Cunningham EB; Hazarizadeh B; Low-Beer D; Luhmann N; Webb P; Hickman M; Vickerman P, 2025, 'Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis', Lancet Gastroenterology and Hepatology, 10, pp. 315 - 331, http://dx.doi.org/10.1016/S2468-1253(24)00442-4

Wheeler A; Masters J; Pradhan A; Roth JM; Degenhardt L; Dore GJ; Matthews GV; Cunningham EB; Peacock A; Colledge-Frisby S; Grebely J; Hajarizadeh B; Martinello M, 2025, 'Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf108

Stevens A; Lafferty L; Treloar C; Cunningham EB; Dore GJ; Grebely J; Marshall AD, 2025, 'Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection', International Journal of Drug Policy, 137, pp. 104720 - 104720, http://dx.doi.org/10.1016/j.drugpo.2025.104720

Dore GJ, 2025, 'Monitoring hepatitis C elimination among people who inject drugs: A broader approach is required', International Journal of Drug Policy, 137, http://dx.doi.org/10.1016/j.drugpo.2025.104712

Young C; Singh M; Jackson KJL; Field MA; Peters TJ; Angioletti-Uberti S; Frenkel D; Ravishankar S; Gupta M; Wang JJ; Agapiou D; Faulks ML; Al-Eryani G; Luciani F; Gordon TP; Reed JH; Danta M; Carr A; Kelleher AD; Dore GJ; Matthews G; Brink R; Bull RA; Suan D; Goodnow CC, 2025, 'A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease', Immunity, 58, pp. 412 - 430.e10, http://dx.doi.org/10.1016/j.immuni.2024.12.011

McKetin R; Degan TJ; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly PJ; Turner A; Clare PJ; Dean OM; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BTF; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Byrne M; Russell S; Zahra E; Berk M, 2024, 'A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial', Trials, 25, http://dx.doi.org/10.1186/s13063-024-08238-y

Martinello M; Carson JM; Post JJ; Finlayson R; Baker D; Read P; Shaw D; Bloch M; Doyle J; Hellard M; Filep E; Hosseini-Hooshyar S; Dore GJ; Matthews GV, 2024, 'Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae665

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, http://dx.doi.org/10.1038/s41467-024-47720-8

Bah R; Sheehan Y; Li X; Dore GJ; Grebely J; Lloyd AR; Hajarizadeh B; Bah R; Li C; Byrne M; Butler T; Musarurwa B; Hooshmand E; Simpson A; Alrayyani M; Price N; Groom M, 2024, 'Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep study', Lancet Regional Health Western Pacific, 53, http://dx.doi.org/10.1016/j.lanwpc.2024.101240

MacLachlan JH; Allard N; Tran L; Savage A; Adamson E; Price V; Pearce C; Dore GJ; Cowie BC, 2024, 'Uptake of guideline-based testing for chronic viral hepatitis in Australian primary care: retrospective analysis of electronic medical record data', Australian Journal of Primary Health, 30, http://dx.doi.org/10.1071/PY24143

Marshall AD; Conway A; Cunningham EB; Valerio H; Silk D; Alavi M; Tillakeratne S; Wade A; Lam T; Zohrab K; Dunlop A; Connelly C; Cock V; Burns C; Henderson C; Christmass M; Dore GJ; Grebely J, 2024, 'A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage Study', Viruses, 16, http://dx.doi.org/10.3390/v16111763

Ryan H; Dore GJ; Grebely J; Byrne M; Cunningham EB; Martinello M; Lloyd AR; Hajarizadeh B, 2024, 'Hepatitis C treatment outcome among people in prison: The SToP-C study', Liver International, 44, pp. 2996 - 3007, http://dx.doi.org/10.1111/liv.16074

Tillakeratne S; Pearson SA; Alavi M; Hajarizadeh B; Martinello M; Law M; George J; Amin J; Matthews G; Grebely J; Dore GJ; Valerio H, 2024, 'Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia', Lancet Regional Health Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101185

Maher L; Wand H; Heard S; Starr M; Zolala F; Kemp R; Cunningham P; Drummer H; Hellard M; Kaldor J; Dore G, 2024, 'Utilising Integrated Bio-behavioural Surveillance (IBBS) to investigate declining hepatitis C antibody prevalence among people who inject drugs in the Australian Needle and Syringe Program Survey', International Journal of Drug Policy, 131, http://dx.doi.org/10.1016/j.drugpo.2024.104545

Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C, 2024, 'Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study', International Journal of Drug Policy, 129, http://dx.doi.org/10.1016/j.drugpo.2024.104477

Valerio H; Alavi M; Marshall AD; Hajarizadeh B; Amin J; Law M; Tillakeratne S; George J; Degenhardt L; Grebely J; Matthews GV; Dore GJ, 2024, 'Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population-based study', Drug and Alcohol Review, 43, pp. 1080 - 1092, http://dx.doi.org/10.1111/dar.13688

Murdock NA; Alajaji NE; Schaefer R; Boone CA; Campo RE; Dore GJ; Gandhi M; Gorospe JR; Gulick RM; Hodder SL; Liu J; Rhee MS; Rooney JF; Vannappagari V; Wilkin T; Miller V, 2024, 'Long-acting HIV Treatments: Study Design, Logistics, and Access', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae337

Broady TR; Valerio H; Alavi M; Wheeler A; Silk D; Martinello M; Conway A; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Treloar C; Grebely J, 2024, 'Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104468

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Valerio H; Marshall AD; Conway A; Treloar C; Carter L; Martinello M; Henderson C; Amin J; Read P; Silk D; Degenhardt L; Prain B; Alavi M; Dore GJ; Grebely J, 2024, 'Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104394

Farooq A; Valerio H; Wheeler A; Martinello M; Henderson C; Silk D; Degenhardt L; Read P; Dore GJ; Grebely J; Cunningham EB, 2024, 'Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study', Drug and Alcohol Review, 43, pp. 1019 - 1028, http://dx.doi.org/10.1111/dar.13828

Price O; Swanton R; Grebely J; Hajarizadeh B; Webb P; Peacock A; Dore GJ; Cowie BC; Vickerman P; Degenhardt L, 2024, 'Vaccination coverage among people who inject drugs: A systematic review', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104382

Price O; Dietze P; Maher L; Dore GJ; Sutherland R; Salom C; Bruno R; Crawford S; Degenhardt L; Larney S; Peacock A, 2024, 'High COVID-19 vaccine uptake following initial hesitancy among people in Australia who inject drugs', Vaccine, 42, pp. 2877 - 2885, http://dx.doi.org/10.1016/j.vaccine.2024.03.051

Back to profile page